MedTrace Logo

Comparison of Insulin Glargine and NPH Insulin at Night and at Hypoglycemia in Type 2 Diabetes

NCT00468364 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2007-08-30

No results posted yet for this study

Summary

Long-acting insulin injected at bedtime may cause hypoglycemia (low blood sugar) in the night in patients with diabetes. The aims of the study are 1) to compare the dynamic characteristics of long-acting insulin analog glargine with those of NPH insulin and placebo during the night and the early morning hours, 2) investigate differences on glucose metabolism of bedtime glargine versus NPH insulin at induced hypoglycemia.

Conditions

Interventions

DRUG

insulin glargine

DRUG

NPH insulin

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • University of Giessen

    lead OTHER

Principal Investigators

  • Thomas Linn, MD · Justus Liebig University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Completion
2006-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00468364 on ClinicalTrials.gov